![Marsha Fanucci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marsha Fanucci
Direktor/Vorstandsmitglied bei
GENERATE BIOMEDICINES, INC.
Vermögen: - $ am 31.05.2026
Profil
Marsha H.
Fanucci is currently a Non-Executive Director at Generate Biomedicines, Inc. since 2025 and a Director at The Schwartz Center for Compassionate Healthcare.
Former roles include Chairman at Cyclerion Therapeutics, Inc., Director at Forma Therapeutics, Inc. from 2014 to 2022, Independent Director at Momenta Pharmaceuticals, Inc. from 2011 to 2016, Independent Director at Ironwood Pharmaceuticals, Inc. from 2009 to 2019, Independent Non-Executive Director at Forma Therapeutics Holdings, Inc. from 2014 to 2022, Independent Director at Alnylam Pharmaceuticals, Inc. from 2010 to 2023, Independent Director at Syros Pharmaceuticals, Inc. from 2015 to 2025, Vice President-Corporate Development & Strategy at Genzyme Corp.
from 1998 to 2000, Vice President at Arthur D.
Little, Inc. from 1998 to 2000, and Chief Financial Officer & Senior Vice President at Millennium Pharmaceuticals, Inc. from 2004 to 2009.
Education includes an MBA from Northeastern University and undergraduate studies at West Virginia University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Marsha Fanucci
| Unternehmen | Position | Beginn |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Direktor/Vorstandsmitglied | 01.03.2025 |
The Schwartz Center for Compassionate Healthcare | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marsha Fanucci
| Unternehmen | Position | Ende |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.02.2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.09.2023 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 14.10.2022 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Direktor/Vorstandsmitglied | 01.10.2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
Ausbildung von Marsha Fanucci
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
 West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Schwartz Center for Compassionate Healthcare | |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
